Factors of Cardiovascular Risk in Patients with Arterial Hypertension at Various Levels of Thyroid Stimulating Hormone

V.Yu. Pryhodko, O.A. Kononenko

Abstract


The objective was to determine the effect of thyroid stimulating hormone (TSH) levels on the incidence and severity of cardiovascular risk factors in patients with arterial hypertension (AH). We have examined 123 patients with AH I–II grades aged 45–70 years. Methods of examination: blood lipids, TSH, free thyroxine, echocardiography, office blood pressure (BP) measurement, duplex scanning of neck vessels, testing by hospital anxiety and depression scales. Among the examined patients, 12.4 % had subclinical hypothyroidism not previously diagnosed that was associated with greater incidence of dyslipidemia, carbohydrate metabolism disorders, left ventricular hypertrophy and carotid atherosclerotic lesions, higher values of pulse BP, as well as with a decrease in glomerular filtration rate and with anxiety-depressive disorders. Analysis of the group with normal thyroid function found that high normal TSH level (2–4 mU/L) is also associated with increased incidence of cardiovascular risk factors and the deterioration of target organs compared with those with low-normal TSH levels. Thus, the functional state of the thyroid gland has an impact on the incidence and severity of risk factors and target organ damage in AH that requires its careful monitoring in patients with cardiological diseases.


Keywords


hypertension; age; cardiovascular risk factors; functional status of the thyroid gland.

References


BakIrova N.M. Osobennosti techeniya arterialnoy gipertonii u pozhilyih bolnyih s subklinicheskoy disfunktsiey schitovidnoy zhelezyi.//Avtoreferat disertatsIYi na zdobuttya naukovogo stupenya kandidata medichnih nauk. – Izhevsk – 2013. – 21s.

Blankova Z.N., Ageev F.T.i dr. Gipotireoz i serdechno-sosudistyie zabolevaniya. // Novosti meditsinyi i farmatsii. – 2014. – #512. – s.5-13

Budnevskiy A. V., Kaverzina M. Yu. Kachestvo zhizni i osobennosti terapii subklinicheskogo gipotireoza u bolnyih ishemicheskoy boleznyu serdtsa. Prikladnyie informatsionnyie aspektyi meditsinyi. 2014; 14(1): 52-57.

KlInIchnI rekomendatsIYi z arterIalnoYi gIpertenzIYi Evropeyskogo tovaristva gIpertenzIYi (ESH) ta Evropeyskogo tovaristva kardIologIv (ESC) 2013 roku. Naukoviy redaktor perekladu SIrenko Yu.M.// ArterIalna gIpertenzIya. – 2013. – #4. – 160s.

Levchenko I.A., FadEEv V.V. Subklinicheskiy gipotireoz.// Problemyi endokrinologii. – 2002 – #2 . – c.13-22.

Melnichenko G.A. Subklinicheskiy gipotireoz: problemyi lecheniya//G.A.Melnichenko, Fadeev V.V./ Vrach – 2002 — #7 – S. 41-43.

MItchenko O.I., Romanov V.Yu., Gvozdik M.V. RannI markeri aterosklerozu v zhInok z gIpertonIchnoyu hvoroboyu ta metabolIchnim sindromom na tlI subklInIchnogo gIpotireozu.//UkraYinskiy kardIologIchniy zhurnal. – 2014. – #1. – s.42-48.

Mitnik Z.M. ta In. Stan endokrinologIchnoYi sluzhbi UkraYini v 2007 r. ta perspektivi rozvitku medichnoYi dopomogi hvorim z endokrinnoyu patologIEyu // Statistichno-analItichniy dovIdnik MOZ UkraYini ta UkraYinskogo naukovo-praktichnogo tsentru endokrinnoYi hIrurgIYi, transplantatsIYi endokrinnih organIv I tkanin. — K., 2008. — s.49

NAMN UkraYini, DU «NatsIonalniy naukoviy tsentr Institut kardIologIYi ImenI akad. M.D.Strazheska» Hvorobi sistemi krovoobIgu yak mediko-sotsIalna I suspIlno-polItichna problema. (AnalItichno-statistichniy posIbnik). – KiYiv – 2014. – 279s.

Smulevich A.B. Psihokardiologiya // A.B. Smulevich, A.L. Syirkin/ M., 2005., S.777

Feskova A. A. Znachenie subklinicheskogo gipotireoza v patogeneze zabolevaniy serdechno-sosudistoy sistemyi (obzor literaturyi) / A. A. Feskova, E. S. Drobyisheva // Molodoy uchenyiy. — 2014. — #17. — S. 207-210.

Gabriela Brenta Saharnyiy diabet i schitovidnaya zheleza Perevod O.I. Vinogradskoy, pod redaktsiey V.V. Fadeeva// Zhurnal Tironet, 2011,#3;

Al Sayed A, Al Ali N, Bo Abbas Y, Alfadhli E. Subclinical hypothyroidism is associated with early insulin resistance in Kuwaiti women. Endocrine Journal 2006;53:653–657.

Asvold BO, Vatten LJ, Nilsen TI, Bjoro T 2007 The associationт between TSH within the reference range and serum lipid concentrations in a population-based study. The HUNT Study. Eur J Endocrinol 156:181.186

Boggio A, Muzio F, Fiscella M, Sommariva D, Branchi A 28 December 2011 Is thyroid-stimulating hormone within the normal reference range a risk factor for atherosclerosis in women? Intern Emerg Med doi: 10.1007/s11739-011-0743-z

Cabral M.D., Teixeira P.F., Silva N.A. et al. Normal flow-mediated vasodilatation of the brachial artery and carotid artery intima-media thickness in subclinical hypothyroidism. //Braz. J. Med. Biol. Res. – 2009. – 42(5): 426-432.

Chiche F., Jublanc C., Coudert M. et al. Hypothyroidism is not associated with increased carotid atherosclerosis when cardiovascular risk factors are accounted for in hyperlipidemic patients..// Atherosclerosis. – 2009. – 203(1): 269.276.

De Pergola G, Ciampolillo A, Alo` D, Sciaraffia M, Guida P 2010 Free triiodothyronine is associated with smoking habit, independently of obesity, body fat distribution, insulin, and metabolic parameters. J Endocrinol Invest 33:815-818.

Fernandez-Real JM, Lo. pez-Bermejo A, Castro A, Casamitjana R, Ricart W 2006 Thyroid function is intrinsically linked to insulin sensitivity and endothelium-dependent vasodilation in healthy euthyroid subjects. J Clin Endocrinol Metab 91:3337–3343

Furong Wang, Yinyin Tan, Chenggang Wang,J et al. Thyroid-Stimulating Hormone Levels within the Reference Range Are Associated with Serum LipidProfiles Independent of Thyroid Hormones//Clin Endocrinol Metab – 2012 – №97(8):2724–2731

Canaris G. J., Manowitz N. R., Mayor G., Ridgway E. C. The Colorado Thyroid disease prevalence study. Arch. Intern. Med. 2000;160: 526–534.

Gardun˜ o-Garcia Jde J, Alvirde-Garcia U, Lo. pez-Carrasco G, Padilla Mendoza ME, Mehta R, Arellano-Campos O, Choza R, Sauque L, Garay-Sevilla ME, Malacara JM, Gomez-Perez FJ, Aguilar-Salinas CA2010TS Hand free thyroxine concentrations are associated with differing metabolic markers in euthyroid subjects. Eur J Endocrinol 163:273-278.

Hak A. E., Pols H. A., Visser T. J., Drexhage H. A., Hofman A., Witteman J. C. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann. Intern. Med. 2000; 132: 270-278.

Howland R.H. Thyroid dysfunction in refractory depression: implications for pathophysiology and treatment. // J Clin Psychiatry. - 1993. - Vol. 54, № 2. - P. 47-54.

Joffe R. T., Levitt A. J. Major depression and subclinical (grade 2) hypothyroidism. // Psychoneuroendocrinology. - 1992. - Vol.17, № 2 - 3.- P. 215-221.

Kumar HK, Yadav RK, Prajapati J, Reddy CV, Raghunath M, Modi KD2009 Association between thyroid hormones, insulin resistance, and metabolic syndrome. Saudi Med J 30:907-911.

Lu L, Wang B, Shan Z, Jiang F, Teng X, Chen Y, Lai Y, Wang J, Xue H, Wang S, Li C, Liu H, Li N, Yu J, Shi L, Hou X, Xing Q, Bai X, Teng W 2011 The correlation between thyrotropin and dyslipidemia in a population-based study. J Korean Med Sci 26:243-249.

McQuade C, Skugor M, Brennan DM, Hoar B, Stevenson C, Hoogwerf BJ 2011 Hypothyroidism and moderate subclinical hypothyroidism are associated with increased all-cause mortality independentof coronary heart disease risk factors: a PreCIS database study. Thyroid 21:837-843.

Park SB, Choi HC, Joo NS 2011 The relation of thyroid function to components of the metabolic syndrome in Korean men and women. J Korean Med Sci 26:540-545.

Pearce EN 2012 Update in lipid alterations in subclinical hypothyroidism. J Clin Endocrinol Metab 97:326-333.

Posadas-Romero C et al. Fatty liver largely explains associations of subclinical hypothyroidism with insulin resistance, metabolic syndrome, and subclinical coronary atherosclerosis.// Eur J Endocrinol. 2014 – 171(3):319-25

Rodondi N, den Elzen WP, Bauer DC, Cappola AR, Razvi S, Walsh JP, Asvold BO, Iervasi G, Imaizumi M, Collet TH, Bremner A, Maisonneuve P, Sgarbi JA, Khaw KT, Vanderpump MP, Newman AB, Cornuz J, Franklyn JA, Westendorp RG, Vittinghoff E, Gussekloo J 2010 Thyroid studies collaboration. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA 304:1365–1374

Roos A, Bakker SJ, Links TP, Gans RO, Wolffenbuttel BH 2007 Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects. J Clin Endocrinol Metab 92:491–496

Ruhla S, Weickert MO, Arafat AM, Osterhoff M, Isken F, Spranger J, Scho. fl C, Pfeiffer AF, Mo. hlig M 2010 A high normal TSH is associated with the metabolic syndrome. Clin Endocrinol (Oxf) 72: 696–701

Sharma R, Sharma TK, Kaushik GG, Sharma S, Vardey SK, SinhaM 2011 Subclinical hypothyroidism and its association with cardiovascularrisk factors. Clin Lab 57:719–72

Surks MI, Goswami G, DanielsGH 2005 The thyrotropin reference range should remain unchanged. J Clin Endocrinol Metab 90:5489–5496

Takashima N., Niwa Y., Mannami T. et al. (2007) Characterization of subclinical thyroid dysfunction from cardiovascular and metabolic viewpoints: the Suita study. Circ. J., 71(2): 191–195.

Velkoska Nakova V, Krstevska B, Bosevski M, Dimitrovski Ch, Serafimoski V 2009 Dyslipidaemia and hypertension in patients with subclinical hypothyroidism. Prilozi 30:93–102

Vierhapper H., Nardi A., Grosser P., et al. Lowdensity lipoprotein cholesterol in subclinical hypothyroidism. // Thyroid. – 2000. – Vol. 10. – P. 981-984.

Volzke H, Robinson DM, Spielhagen T, Nauck M, Obst A, Ewert R, Wolff B, Wallaschofski H, Felix SB, Do. rr M 2009 Are serum thyrotropin levels within the reference range associated with endothelial function?// Eur Heart J – 2009 – Vol.30:217-224.

Waring AC, Rodondi N, Harrison S, Kanaya AM, Simonsick EM, Miljkovic I, Satterfield S, Newman AB, Bauer DC. Thyroid function and prevalent and incident metabolic syndrome in older adults: the health, ageing and body composition study.// Clin Endocrinol (Oxf) 2012;76:911-918.

Westerink J, van der Graaf Y, Faber DR, Spiering W, Visseren FL Relation between thyroid-stimulating hormone and theoccurrence of cardiovascular events and mortality in patients with manifest vascular diseases. //J Clin Endocrinol Metab – 2012 – 97(8):2724-2731. D. John Betteridge Lipids: Current Perspectives// CRC Press – 1996 – P. 312

Scott M. Grundy Atlas of Atherosclerosis and Metabolic Syndrome// Springer Science& Business Media – 2011 – P. 314.




DOI: https://doi.org/10.22141/2224-0721.1.73.2016.71073

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© "Publishing House "Zaslavsky", 1997-2017

 

 Яндекс.МетрикаSeo анализ сайта Рейтинг@Mail.ru